The Cancer data commentaries series has been created within Cancer data in Australia to communicate key findings within the data, to help increase cancer awareness and to improve the understanding of cancer trends in Australia.
Cancer data commentaries released in 2022
| Commentary no. |
Title and content overview |
Release date |
| C9 |
Prostate cancer – projection method changes, updated long-term prostate cancer incidence projections
This commentary provides greater detail of the prostate cancer incidence projection method change already available in the July release of this report. The commentary also provides updated longer-term prostate cancer incidence projections, notes limitations and difficulties projecting incidence for this cancer. The ageing population’s impact on prostate cancer incidence and mortality is discussed within the commentary.
|
04/10/2022 |
| C8b |
Interim guidelines – choosing which mortality data source to use (2022 release)
This commentary suggests the recommended mortality data source (either the Australian Cancer Database or the National Mortality Database) for the various cancers reported on within this report. The recommendations are not prescriptive and are provided for those who wish assistance. Some further general advice to help address possible cancer mortality reporting issues is also discussed.
|
04/10/2022 |
| C8 |
Cancer mortality data investigations (preliminary investigations)
Using National Mortality Database (NMD) and Australian Cancer Database mortality data comparisons, this commentary explores potential limitations in using the NMD to report on mortality for some cancers. It discusses the complexity of establishing the underlying cause of death and the corresponding issues these may have on mortality reporting for some cancers.
|
01/07/2022 |
Cancer data commentaries released prior to 2022 contain data that was up-to-date at the time but may change as CdiA is updated.
The data presented in the Cancer data commentaries are available in the supplementary tables.